Knowledge Center

Presentation / Sep 10, 2015

Screening methodologies to expedite the formulation development of amorphous solid dispersions

Authors:
  • Iris Duarte
  • Joao Henriques
  • Joao F. Pinto
  • Marcio Temtem
Source:
2015 APS Presentation, Íris Duarte

Related links

2015 APS Presentation - Screening methodologies

Also in the Knowledge Center

Related Content

Inhalation grade particles

Hovione is a global expert in particle engineering, an essential technology when developing inhalation drug products.

Page
Read more

Devices

Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.

Page
Read more

Drug Substance Sustainability

At Hovione, sustainability is embedded into every stage. Guided by sustainability-by-design and over 20 years of Green Chemistry expertise, we deliver cleaner, smarter, and more efficient solutions - helping you reduce environmental impact, meet regulatory expectations, and improve process performance.

Page
Read more